-
We analyze both open- and closed-access publications All of our open-access content includes articles published on PubMed Central within the last 15 years, including many papers that are subject to the National Institute of Health (NIH) 2...
-
We are happy to hear that the ASCEND by BenchSci platform has been useful for your research! Users can reference ASCEND the same way you would reference any website or database using your citation style of choice such as MLA or APA ...
-
The knowledge center widget integrates guide content from the knowledge center website ( knowledge.benchsci.com/home ) with the application ( app.benchsci.com ) This widget is an alternative way for you to access existing articles in the knowl...
-
We are excited to announce new enhancements on the platform between April and June 2022 Over the past three months, we’ve added data from over 27.1 million experiments and 4.2 million products across our reagent and model system types. Othe...
-
Thank you for your interest in creating an account! Please email support@benchsci.com if you have any questions! 1. Go to signup/login page: app.benchsci.com Check out this article to learn more about eligibility to sign up for ...
-
Similar to any web-based platform, a browser refresh or computer restart may fix the problem Here are some things you could try if you are having trouble loading a page, or are experiencing strange behaviour on the website: Try logging out a...
-
There are a few ways to get in touch with us! Feel free to reach out to our Scientific Support team through one of these methods. Someone will be in touch within 1 business day! In-app Chat Email Request Form Click at the...
-
Scientists can log into the ASCEND by BenchSci platform using email/password or through single-sign-on (SSO) 1. If you work for a company with an enterprise license — click your logo here to log in now: 2. If your logo is not listed, v...
-
Not all of our data are in the public domain, so we require registration Not all of the content in BenchSci's database is in the public domain. In addition to data from open-access journals, we also present data from closed-access journals thro...
-
We are excited to announce new enhancements to the platform between January - March 2022. This quarter, we added data from over 1,000,000 experiments and 800,000 products to our antibody data. In addition, we added preprint data from bio...